Freestone Capital Holdings »

Anavex Life Sciences shares owned by Freestone Capital Holdings

Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Freestone Capital Holdings from 13F filings

Historical chart of Freestone Capital Holdings investment in Anavex Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences held by Freestone Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences by Freestone Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $90k 14k 6.55
2023-06-30 $81k 10k 8.13

More positions owned by Freestone Capital Holdings

Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Apple (AAPL)
Nike CL B (NKE)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation Put Option (NVDA)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)

View all positions for Freestone Capital Holdings

Top funds holding Anavex Life Sciences

Vanguard Group
DLD Asset Management
Nwam
Citadel Advisors
Charles Schwab Investment Management
SG Americas Securities
Goldman Sachs Group
Bank of New York Mellon
UBS Group
Point72 Asset Management
Barclays
Bank of America Corporation
Swiss National Bank
State of Wisconsin Investment Board
Jane Street

View all funds holding Anavex Life Sciences